-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SqlDsI7S1TyY5T6oGfT4xnyCFYNj2zY1Ez8ZsMyKVHQ4xSeX9vy0Sowc+9XWXeJp 36zvw8L99NE1jHir0RmjGw== 0001179110-05-016723.txt : 20050819 0001179110-05-016723.hdr.sgml : 20050819 20050819164024 ACCESSION NUMBER: 0001179110-05-016723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050111 FILED AS OF DATE: 20050819 DATE AS OF CHANGE: 20050819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSSETTOS NICHOLAS J CENTRAL INDEX KEY: 0001167450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27282 FILM NUMBER: 051038988 BUSINESS ADDRESS: BUSINESS PHONE: 2122672503X203 MAIL ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 5507 CITY: NEW YORK STATE: NY ZIP: 10118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544555 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 edgar.xml FORM 4 - X0202 4 2005-01-11 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHTT 0001167450 ROSSETTOS NICHOLAS J 810 SEVENTH AVENUE, 4TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Financial Officer Stock Options 20.94 2010-04-12 Common Stock 10000 10000 D Stock Options 4.375 2011-02-20 Common Stock 10000 10000 D Stock Options 1.25 2012-02-19 Common Stock 10000 10000 D Stock Options 1.25 2012-02-19 Common Stock 10000 10000 D Stock Options 1 2002-03-28 2012-03-28 Common Stock 25000 25000 D Stock Options .4 2013-02-24 Common Stock 292030 292030 D Stock Options 1.25 2012-02-19 Common Stock 10000 10000 D Stock Options 1.65 2014-01-28 Common Stock 150000 150000 D Stock Options 1 2005-01-11 4 A 0 50000 0 A 2015-01-11 Common Stock 50000 50000 D (Right to buy) Currently exercisable. 2,500 shares vest on each of 2/20/01, 2/20/02, 2/20/03 and 2/20/04. 2,500 shares vest on each of 2/19/02, 2/19/03, 2/19/04 and 2/19/05. 146,015 shares are currently vested; 146,015 shares vest on 2/24/05. Option vests on the earlier of FDA approval or Catarex or 2/19/07. 50,000 shares vest on each of 1/28/04, 1/28/05 and 1/28/06. 25,000 shares vest on each of 1/3/06 and 1/3/07. /s/ Nicholas J. Rossettos 2005-08-19 -----END PRIVACY-ENHANCED MESSAGE-----